This week brought good news and bad news for companies on the antitrust front.
The Department of Justice is suing to block a duo of health insurance mega deals inked last year—Anthem’s $54 billion acquisition of Cigna and Aetna’s $37 billion acquisition of Humana. But the dozen law firms that won work on Anheuser-Busch InBev’s $106 billion megamerger with SABMiller, announced in November, have reason to toast again. On Wednesday, the Justice Department cleared the pairing, with AB InBev agreeing to several conditions.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
